Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)
Sponsors
Bayer
Conditions
Clinical Pharmacology
Phase 1
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufacturers Under Fasted Conditions in Healthy Adult Subjects
CompletedNCT03517930
Start: 2018-04-17End: 2018-07-20Updated: 2018-09-19
A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects
CompletedNCT03517943
Start: 2018-04-24End: 2018-08-30Updated: 2018-09-13